In pediatric EBV-positive PTLD patients with high PD-1 expression by NK cells, the low functional capacity of NK cells, in terms of both IFN-γ production and CD107a cytotoxicity marker expression, can be recovered after in vitro PD-1/PD-L1 blockade [34]. Here, PDCD1 is linked to post-transplant lymphoproliferative disease.